AR075869A1 - Sintesis de azaindoles - Google Patents

Sintesis de azaindoles

Info

Publication number
AR075869A1
AR075869A1 ARP100100848A ARP100100848A AR075869A1 AR 075869 A1 AR075869 A1 AR 075869A1 AR P100100848 A ARP100100848 A AR P100100848A AR P100100848 A ARP100100848 A AR P100100848A AR 075869 A1 AR075869 A1 AR 075869A1
Authority
AR
Argentina
Prior art keywords
azaindoles
synthesis
contacting
produce
alkylpyrazine
Prior art date
Application number
ARP100100848A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR075869A1 publication Critical patent/AR075869A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Reivindicacion 1: Un método para producir un azaindol, que comprende: a) poner en contacto 2-cloropirazina con un reactivo de Grignard para producir una alquilpirazina; b) poner en contacto 4-acetilbenzonitrilo con un reactivo de Grignard para producir un carbinol; c) poner en contacto la alquilpirazina con el carbinol para producir un diazaindol, donde: R = alquilo; R1 = alquilo, arilo o heteroarilo.
ARP100100848A 2009-03-19 2010-03-17 Sintesis de azaindoles AR075869A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16144009P 2009-03-19 2009-03-19
FR0958975 2009-12-15

Publications (1)

Publication Number Publication Date
AR075869A1 true AR075869A1 (es) 2011-05-04

Family

ID=42299194

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100100848A AR075869A1 (es) 2009-03-19 2010-03-17 Sintesis de azaindoles

Country Status (18)

Country Link
US (1) US20120010409A1 (es)
EP (1) EP2408777A1 (es)
JP (1) JP2012520894A (es)
KR (1) KR20120001763A (es)
CN (1) CN102341397A (es)
AR (1) AR075869A1 (es)
AU (1) AU2010226618A1 (es)
BR (1) BRPI1009323A2 (es)
CA (1) CA2755797A1 (es)
IL (1) IL215100A0 (es)
MA (1) MA33130B1 (es)
MX (1) MX2011008557A (es)
NZ (1) NZ595175A (es)
RU (1) RU2011142139A (es)
SG (1) SG174213A1 (es)
TW (1) TW201038577A (es)
UY (1) UY32506A (es)
WO (1) WO2010107969A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115244036A (zh) 2020-02-27 2022-10-25 先正达农作物保护股份公司 杀有害生物活性的二嗪-双酰胺化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12514A (en) * 1999-12-24 2006-05-29 Aventis Pharma Ltd Azaindoles.
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
IL215100A0 (en) 2011-12-29
RU2011142139A (ru) 2013-04-27
BRPI1009323A2 (pt) 2016-03-08
CA2755797A1 (en) 2010-09-23
SG174213A1 (en) 2011-10-28
CN102341397A (zh) 2012-02-01
AU2010226618A1 (en) 2011-10-06
US20120010409A1 (en) 2012-01-12
UY32506A (es) 2010-10-29
TW201038577A (en) 2010-11-01
WO2010107969A1 (en) 2010-09-23
EP2408777A1 (en) 2012-01-25
NZ595175A (en) 2013-01-25
KR20120001763A (ko) 2012-01-04
JP2012520894A (ja) 2012-09-10
MX2011008557A (es) 2011-09-09
MA33130B1 (fr) 2012-03-01

Similar Documents

Publication Publication Date Title
CL2012003629A1 (es) Molecula de acido nucleico aislada que comprende el precursor mir166; constructo de expresion vegetal que comprende dicha molécula; metodo de modulacion en comparacion con una respectiva planta de referencia.
CR20130539A (es) Triazolopiridinas
EA201400712A1 (ru) Основа со структурированной поверхностью, способ изготовления такой основы, а также способ определения ее смачиваемости
EA201201288A1 (ru) Способ применения реактивов гриньяра
EA201391180A1 (ru) Способ получения оптически активных производных дигидробензофурана
CY1119121T1 (el) Αμορφο αλας ενος μακροκυκλικου αναστολεα του hcv
IN2012DN00913A (es)
CY1117163T1 (el) Ιμιδαζοπυριδαζινες ως αναστολεις κινασης ακτ
BR112013001033A2 (pt) processo de fabricação pela embalagem de injetáveis
CR20120387A (es) Composiciones minerales queladas orgánicamente y métodos de ellas
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
WO2011095336A3 (en) Post-synthetic modification of nucleic acids by inverse diels-alder reaction
CL2014003055A1 (es) Procedimiento para preparar una composicion farmaceutica que comprende i) proporcionar una primera combinacion que comprende un compuesto inhibidor del proteasoma peptidico, una o mas ciclodextrinas y agua, y ii) poner en contacto la primera combinacion con un acido para formar una segunda combinacion; composicion farmaceutica.
BR112014006911A2 (pt) aditivos de perda de fluido e métodos de produção e uso dos mesmos
CR20110208A (es) Proceso para la preparación de benzonorbornenos
BR112014014432A2 (pt) método para produzir um composto
EA201300792A1 (ru) Химические соединения
AR075869A1 (es) Sintesis de azaindoles
EA201071025A1 (ru) Способ получения [фенилсульфанилфенил]пиперидинов
DOP2013000287A (es) Método de producción de derivados de imidazol
AR088098A1 (es) Metodos de obtencion de la 5-[2-[7-(trifluorometil)-5-[4-(trifluorometil)fenil]pirazolo[1,5-a]pirimidin-3-il]etinil]-2-piridinamina
CY1116826T1 (el) Μεθοδος ενζυματικης συνθεσης toy (7s) 3,4-ιμεθοξυδικυκλο[4.2.0]οκτα- 1,3,5-τριενο-7-καρβοξυλικου οξεος και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
EA201400882A1 (ru) Способ стереоселективного синтеза 9-гидрокси-5-оксо-1,4-диазаспиро[5.5]ундеканов, содержащих защитные группы в 1,4-положениях
CR20110173A (es) Proceso para la eliminación de cianuro de hidrógeno de etanodinitrilo
RU2013136122A (ru) Способ получения борированных порфиринов

Legal Events

Date Code Title Description
FB Suspension of granting procedure